However, patients with AMI and OSA exhibited elevated levels of CK (1430, 301–5432 vs. 377, 125–2194 U/L; p = 0.036), CK-MB (64, 15–300 vs. 9, 4–148 ng/mL; p = 0.044), and cTnT (2298, 382–17854 vs. 356, 142–1021 pg/mL; p = 0.041). The gene discussed is TNNT2; the disease is obstructive sleep apnea syndrome.